ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms do not affect methadone maintenance treatment in HCV-positive patients
By: Davorka Sutlović, Željko Ključević and Sendi Kuret
Authors
Davorka Sutlović
University of Split, Department for Health Studies, Split, Croatia
University of Split School of Medicine, Department of Toxicology and Pharmacogenetics, Split, Croatia
Željko Ključević
Public Health Institute of the Split-Dalmatia County, Department of Mental Health, Prevention and Outpatient Addiction Treatment, Split, Croatia
Sendi Kuret
University of Split, Department for Health Studies, Split, Croatia
University Hospital Centre Split, Department of Pathology and Forensic Medicine, Split, Croatia
Language: English, Croatian, Slovenian
Page range: 353 - 358
Submitted on: Dec 1, 2019
Accepted on: Nov 1, 2020
Published on: Dec 31, 2020
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2020 Davorka Sutlović, Željko Ključević, Sendi Kuret, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.